Giant cell tumor: rapid recurrence after cessation of long-term denosumab therapy
- 26 February 2015
- journal article
- case report
- Published by Springer Nature in Skeletal Radiology
- Vol. 44 (7) , 1027-1031
Abstract
We report a case of rapid recurrence of a giant cell tumor (GCT) of the distal radius in a 24-year-old woman following the cessation of long-term denosumab therapy. GCT of bone is a histologically benign tumor with multinucleated giant cells on a background of mononuclear giant cells usually presenting as a well-defined epi-metaphyseal lytic lesion without sclerotic margins. Denosumab, a monoclonal antibody to the receptor activator of nuclear factor kappa-B ligand (RANKL), has proven to be an effective neoadjuvant treatment for GCT. The tumor in this case had demonstrated a good response with sustained control for over 2 years while on denosumab therapy. However, within 2 months of cessation of therapy, the tumor demonstrated rapid recurrence and progression with growth, osteolysis, and increased soft tissue component. Despite reinitiating denosumab therapy, there was progressive tumor growth and destruction, ultimately necessitating below-the-elbow amputation. This case illustrates the need for maintenance of denosumab therapy for GCT of bone or definitive surgical treatment prior to its cessation.Keywords
This publication has 24 references indexed in Scilit:
- Sustained long-term complete regression of a giant cell tumor of the spine after treatment with denosumabThe Spine Journal, 2014
- Radiological and pathological characteristics of giant cell tumor of bone treated with denosumabDiagnostic Pathology, 2014
- Effects of denosumab on pain and analgesic use in giant cell tumor of bone: Interim results from a phase II studyActa Oncologica, 2014
- Denosumab Treatment of Metastatic Giant-Cell Tumor of Bone in a 10-Year-Old GirlJournal of Clinical Oncology, 2013
- Giant Cell Tumor of Bone: Review, Mimics, and New Developments in TreatmentRadioGraphics, 2013
- Giant-cell tumor of bone, anti-RANKL therapyBoneKEy Reports, 2012
- Denosumab Induces Tumor Reduction and Bone Formation in Patients with Giant-Cell Tumor of BoneClinical Cancer Research, 2012
- Giant cell tumor of bone: treatment and outcome of 214 casesJournal of Cancer Research and Clinical Oncology, 2008
- Molecular Profiling of Giant Cell Tumor of Bone and the Osteoclastic Localization of Ligand for Receptor Activator of Nuclear Factor κBThe American Journal of Pathology, 2005
- Giant Cell Tumor of Long Bone: A Canadian Sarcoma Group StudyClinical Orthopaedics and Related Research, 2002